NanoString Blog
Home » Blog
Oncology
Statistically Significant Results without the Headache. Q&A with Sarah Church, Ph.D., Senior Scientist at NanoString.
Talking to Sarah, whether during social gatherings or within the office walls, is always a pleasure. Dr. Church is a Senior Scientist at NanoString and one of the warmest people…
Laura Tabellini Pierre /
July 27, 2020
Immunology Infectious Disease
COVID-19 Pathogenesis Steps Out of the Shadows
"Analysis of pulmonary vessels showed that widespread thrombosis with microangiopathy ─ a severe condition wherein small blood clots are formed within the tiniest of blood vessels ─ was 9x more…
Laura Tabellini Pierre /
July 20, 2020
Spotlight on a CRO: Interview with the Team of Scientists behind NeoGenomics Pharma Services
NeoGenomics is a cancer diagnostics and pharma services company serving pharmaceutical companies and academic centers. They specialize in diagnostic, prognostic and predictive testing using the most innovative technologies. The company…
Laura Tabellini Pierre /
July 8, 2020
Oncology
Going Beyond PDL-1. Q&A with Dr. Nina Radosevic- Robin, MD.
Dr. Nina Radosevic-Robin, MD, is a Board-Certified Surgical/Molecular Pathologist at Centre Jean Perrin, a Sr. Scientist within the Unit 1240 of French National Institute for Medical Research (INSERM), and a…
Laura Tabellini Pierre /
June 22, 2020
Immunology Oncology
Why is Spatial Transcriptomics Critical to Studying Sarcomas? Q&A with Dr. Troy McEachron, Ph.D
“Whereas the EWS specimens tended to have very simple genomes, the osteosarcoma specimens looked like a hand grenade had gone off in the genome. These were the most fragmented and…
Laura Tabellini Pierre /
June 15, 2020
Grants Transplants
Solid Organ Transplantation and the Immunology of Rejection. Q&A with GeoMx® Digital Spatial Profiler Grant Winner Dr. Fadi Issa
"Cancer immunotherapy and transplantation are basically the same field; one’s just the flip side of the other". Dr. Fadi Issa Have you ever been to Oxford? Situated in the gorgeous…
Laura Tabellini Pierre /
June 8, 2020
Grants Transplants
Searching for New Biomarkers to Prevent Organ Transplant Rejection. Q&A with HOT Panel Grant Winner Dr. Evan Farkash
Bob’s first question to me was: “How much do you want to learn about kidney pathology?” My response was that I wanted to learn as much as I could, and…
Laura Tabellini Pierre /
June 1, 2020
Spotlight on a CRO. Q&A with Dr. Edward J. Weinstein, Ph.D., CEO and co-founder of Canopy BioSciences.
There is a lot to love in the beautiful city of St. Louis: from the quiet neighborhoods permeated with old world charm to the picturesque streets reminiscent of Paris “petites…
Laura Tabellini Pierre /
May 25, 2020
Oncology
Top Ten Challenges in Cancer Immunology & Immunotherapy
Laura Tabellini Pierre /
May 18, 2020
Grants
Research Grant Preparation: Tips and Resources
Grant writing is a critical, albeit time-consuming, part of every scientist’s job. It is always Grant Writing Time! How often did you end up rushing at the last moment to…
Hiromi Sato /
May 11, 2020
Grants Transplants
Q&A with Paola Cassoni, M.D., Ph.D. on Understanding the Pathway to Organ Rejection.
Turin is a lovely Italian city situated between the western and northern borders of Italy by the Alps, looking east at the Monferrato Hills. The Mole Antonelliana, the proud city…
Laura Tabellini Pierre /
May 4, 2020
Digital Spatial Profiling
Q&A with Dr. Aubrey Thompson, Ph.D.: The GeoMx® Digital Spatial Profiler is Turning the Tables on Breast Cancer
E. Aubrey Thompson, Ph.D is a Professor in the Department of Cancer Biology at the Mayo Clinic in Jacksonville, FL. His research focuses on breast cancer and using genomic and…
Laura Tabellini Pierre /
April 27, 2020